Current role
Kyle Landrum
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Trulieve Cannabis Corp. (TRLV)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Trulieve Cannabis Corp. (TRLV) | Chief Production Officer Represents the grant date fair value of restricted stock unit awards granted in fiscal years 2025, 2024, and 2023 in accordance with ASC Topic 718. Represents the grant date fair value of option awards granted in fiscal years 2025, 2024, and 2023 in accordance with ASC Topic 718, which includes the use of the "simplified" method due to our limited trading history. Represents non-equity incentive plan compensation for each fiscal year based on achievement of qualitative and quantitative performance objectives for each fiscal year as determined by the Compensation and Human Resources Committee. 2025 and 2024 include employer paid portions of premiums for life, dental, and vision insurance, while 2024 also includes 401k match contributions and a health reimbursement arrangement (HRA). 2023 includes employer paid portions of premiums for certain benefits. Mr. Reese's employment with the Company began on September 8, 2025. Mr. Blust was appointed interim CFO effective March 6, 2025, and relinquished his duties upon the appointment of Mr. Reese, effective September 8, 2025. Mr. Getman resigned as CFO effective March 6, 2025. | $350,000 | $1,287,392 |
| 2024 | Trulieve Cannabis Corp. (TRLV) | Chief Production Officer Represents the grant date fair value of restricted stock unit awards granted in fiscal years 2025, 2024, and 2023 in accordance with ASC Topic 718. Represents the grant date fair value of option awards granted in fiscal years 2025, 2024, and 2023 in accordance with ASC Topic 718, which includes the use of the "simplified" method due to our limited trading history. Represents non-equity incentive plan compensation for each fiscal year based on achievement of qualitative and quantitative performance objectives for each fiscal year as determined by the Compensation and Human Resources Committee. 2025 and 2024 include employer paid portions of premiums for life, dental, and vision insurance, while 2024 also includes 401k match contributions and a health reimbursement arrangement (HRA). 2023 includes employer paid portions of premiums for certain benefits. Mr. Reese's employment with the Company began on September 8, 2025. Mr. Blust was appointed interim CFO effective March 6, 2025, and relinquished his duties upon the appointment of Mr. Reese, effective September 8, 2025. Mr. Getman resigned as CFO effective March 6, 2025. | $350,000 | $1,433,792 |
| 2023 | Trulieve Cannabis Corp. (TRLV) | Chief Production Officer Represents the grant date fair value of restricted stock unit awards granted in fiscal years 2025, 2024, and 2023 in accordance with ASC Topic 718. Represents the grant date fair value of option awards granted in fiscal years 2025, 2024, and 2023 in accordance with ASC Topic 718, which includes the use of the "simplified" method due to our limited trading history. Represents non-equity incentive plan compensation for each fiscal year based on achievement of qualitative and quantitative performance objectives for each fiscal year as determined by the Compensation and Human Resources Committee. 2025 and 2024 include employer paid portions of premiums for life, dental, and vision insurance, while 2024 also includes 401k match contributions and a health reimbursement arrangement (HRA). 2023 includes employer paid portions of premiums for certain benefits. Mr. Reese's employment with the Company began on September 8, 2025. Mr. Blust was appointed interim CFO effective March 6, 2025, and relinquished his duties upon the appointment of Mr. Reese, effective September 8, 2025. Mr. Getman resigned as CFO effective March 6, 2025. | $315,000 | $1,004,378 |
| 2022 | Trulieve Cannabis Corp. (TRLV) | Chief Production Officer | $300,000 | $1,259,861 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.